Since efficacy of chemotherapy at cancer spreading stage III-IV is extremely crucial, targeting c-Met in ALDH1 positive breast CSC may possibly decrease the severity of metastatic breast cancer and hence may lead to the survival of breast cancer patients. This evidence concerns the gene ALDH1A1 and breast carcinoma.